跳至主要内容
MedPath Trial Home
临床试验
产品
机构
资讯
AI 研究
价格
Search
EN
登录
我们重视您的隐私
我们使用 Cookie 分析网站流量并改善您的体验。请参阅我们的
隐私政策
。
拒绝
接受
找到 82 条关于
“CD268”
全部
82
临床试验
29
药物
45
机构
0
资讯
8
去年
Enterome Reports Positive Phase 2 Data for EO2463 in Indolent Non-Hodgkin Lymphoma
11个月前
Enterome's EO2463 Receives FDA Fast Track Designation for Follicular Lymphoma Watch-and-Wait Treatment
3个月前
Enterome's EO2463 Receives FDA Orphan Drug Designation for Watch-and-Wait Indolent Non-Hodgkin Lymphoma
4个月前
Enterome's EO2463 Shows Promising CD8 T-Cell Expansion in Phase 2 Indolent Non-Hodgkin Lymphoma Trial
9个月前
Enterome's EO2463 Achieves 100% Response Rate in Follicular Lymphoma Phase 2 Trial
去年
Enterome Secures $19 Million to Advance Novel OncoMimics Immunotherapy for Indolent Non-Hodgkin Lymphoma
去年
Novel CD28 x Nectin-4 Bispecific Antibody Shows Promise in Advanced Bladder Cancer Treatment
14天前
Medicus Pharma Secures Global License from Pfizer for CD228-Targeting ADC, Valued at Over $1 Billion in Milestones